Impact of antimicrobial resistance on patient care | LHSC
Photo: Dr. Ian Ball with screen showing the digital clinical pathways and guidelines developed by the Antimicrobial Stewardship ProgramNovember 20, 2023
VIDEO: No change in concomitant medications after Rebyota for recurrent C . difficile , IBD
CHICAGO — Treatment with Rebyota did not affect concurrent medication use in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection, Jessica R. Allegretti, MD, MPH, explains in this Healio video. Allegretti presented data at Digestive Disease Week on safety outcomes and concomitant medication changes after treatment with Rebyota (fecal microbiota,
Racial disparities in Clostridioides difficile testing in three southeastern US hospitals - PubMed
White patients received more C. difficile tests than Black and NWNB patient groups when controlling for race patient days. Future studies should control for comorbidities and investigate community onset of C. difficile by race and ethnicity.
The practice of fecal microbiota transplantation in inflammatory bowel disease - PubMed
Current evidence posits a central role for gut microbiota and the metabolome in the pathogenesis and progression of inflammatory bowel disease (IBD). Fecal microbiota transplantation (FMT) has been established as a means to manipulate this microbiome safely and sustainably. Several aspects of the te …
Fecal Microbiota Transplantation: Information for the Pediatrician - PubMed
Fecal microbiota transplantation (FMT) involves the delivery of an entire microbial community from a healthy donor to a recipient with the intention of ameliorating or curing a specific disease. Current evidence strongly supports a role for FMT in the treatment of Clostridiodes difficile infection, …
Use the Stool! Fecal Transplants Help Kids With C Diff
The American Academy of Pediatrics endorsed fecal transplants to eliminate a particular infection in children and called for more research about other uses.
Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis - PubMed
Obesity is a risk factor for cognitive dysfunction and neurodegenerative disease, including Alzheimer's disease (AD). The gut microbiota-brain axis is altered in obesity and linked to cognitive impairment and neurodegenerative disorders. Here, we targeted obesity-induced cognitive impairment by test …
NSAIDs Sensitize Colon Cells to C. diff Toxin, Disrupting Mitochondria
Results could provide insights into how NSAID-mediated mitochondrial uncoupling affects diseases such as small intestinal injury, IBD, and colorectal cancer.
Fecal microbiota transplantation regulates the microbiota-gut-spinal cord axis to promote recovery after spinal cord injury - PubMed
Spinal cord injury (SCI) is devastating for patients, and currently lacks effective treatments. Dysbiosis commonly occurs after SCI and has significant immunomodulatory effects, but its impact on recovery remains unclear. The current study investigated the effects and mechanisms of fecal microbiota …
Clostridioides difficile PCR ribotypes 001 and 084 can trigger autophagy process in human intestinal Caco-2 cells - PubMed
Autophagy is a homeostatic process that can promote cell survival or death. However, the exact role of autophagy in Clostridioides difficile infection (CDI) is still not precisely elucidated. Here, we investigate the role of distinct C. difficile ribotypes (RTs) in autophagy induction using Caco-2 c …
A Comparison of the Efficacy of Treatment With Fidaxomicin Versus Vancomycin in Clostridioides difficile Infection
Background Clostridioides difficile infection (CDI) is a major cause of diarrhea in hospitalized adult patients. This study aims to evaluate the clinical characteristics, clinical cure, recur...
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age - PubMed
A narrative review of how infection preventionist (IP) staffing and outcome metrics are assessed by health care organizations and factors to consider - PubMed
This review highlights the need for a new IP staffing model that focuses on a granular assessment of each program and care setting. Additional studies can then be conducted to examine how ideal staffing impacts outcome metrics.
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis - PubMed
Multiple sclerosis (MS) causes long-lasting, multifocal damage to the central nervous system. The complex background of MS is associated with autoimmune inflammation and neurodegeneration processes, and is potentially affected by many contributing factors, including altered composition and function …
Clostridioides difficile utilizes siderophores as an iron source and FhuDBGC contributes to ferrichrome uptake - PubMed
This study is the first example of C. difficile growing with siderophores as the sole iron source and describes the characterization of the ferric hydroxamate uptake ABC transporter (FhuDBGC). This transporter shows specificity to the siderophore ferrichrome. While not required for pathogenes …
Clostridioides difficile infection in neurosurgical patients in a national centre over 10 years: less common but associated with longer hospital stays - PubMed
CDI in neurosurgery patients differed from the wider hospital, with greater awareness of CDI testing. Longer LOS impacted bed utilisation with limited capacity. Robust surveillance supports proactive antimicrobial stewardship programmes in this vulnerable population.
Pro-Survival Pathway Protects from C. difficile Toxin-Mediated Cell Death - PubMed
There is an urgent need for new non-antibiotic based treatment strategies for Clostridioides difficile infection. C. difficile toxin B (TcdB) is a virulent factor that is essential for causing disease. Here, we investigated whether a survival-signaling pathway could protect against TcdB. We found si …
Spatial-temporal simulation for hospital infection spread and outbreaks of Clostridioides difficile - PubMed
Validated and curated datasets are essential for studying the spread and control of infectious diseases in hospital settings, requiring clinical information on patients' evolution and their location. The literature shows that approaches based on Artificial Intelligence (AI) in the development of cli …
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats - PubMed
The results of this study demonstrate that fidaxomicin is highly effective against C. perfringens strains of canine and feline origin. Although fidaxomicin is currently considered a critically important antimicrobial that has not yet been licensed for veterinary use, we consider that the results rep …
Antibiotic Dos and Don’ts: Tips for Staying Healthy While Taking an Antibiotic
Antibiotics can help you feel better after some common illnesses by fighting the bacteria that cause these infections. UR Medicine experts share some lesser-known things that can help you recover as quickly as possible.
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives - PubMed
This review summarizes the application of synthetic biology in intestinal microecology-based therapeutics for major chronic diseases and discusses the opportunities and challenges in the above process, providing clinical possibilities of synthetic biology technology applied in microecological therap …
Microbiome dynamics in rheumatic diseases - PubMed
A deeper comprehension of the microbiome's connection to rheumatism holds potential for enhancing disease diagnosis and treatment. Targeted therapeutic approaches, including probiotics, fecal microbiota transplantation, and combination therapies with medications, offer promising avenues for disease …
Gut Frailty: Its Concept and Pathogenesis - PubMed
Although the concept of gut frailty has not yet gained widespread recognition, we hope to propose more practical screening methods, diagnostic approaches, and specific interventions in the future.